Healthcare >> CEO Interviews >> May 7, 2001
DALE R. PFOST has served as Chairman, President and Chief Executive
Officer of Orchid BioSciences, Inc., since November 1996. Prior to
joining Orchid, Dr. Pfost was President and Chief Executive Officer of
Oxford GlycoSciences in the UK, a leader in proteomics and carbohydrate
engineering. Previous to this position, Dr. Pfost founded Infinitek, the
company that developed the Biomek 1000, and served as General Manager
of the business unit following its acquisition by SmithKline Beckman. He
obtained his BS in Physics from the University of California Santa
Barbara and his MS and PhD degrees in Physics from Brown University. Dr.
Pfost is an inventor on 10 patents and has published numerous scientific
articles in the fields of physics, semiconductors, laboratory
instrumentation and drug discovery. Profile
summary of Orchid?
Dr. Pfost: Orchid is a leading provider of products, services and
technologies for SNP scoring and
